Trade Evotec AG - EVT CFD
Add to favourite- Summary
- Historical Data
Spread | 0.055 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02141% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.000812% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | Germany | ||||||||
Commission on trade | 0% |
Prev. Close | 8.65 |
Open | 8.66 |
1-Year Change | -64.26% |
Day's Range | 8.66 - 8.83 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 8.655 | -0.040 | -0.46% | 8.695 | 8.765 | 8.345 |
Jul 24, 2024 | 8.815 | 0.120 | 1.38% | 8.695 | 8.860 | 8.625 |
Jul 23, 2024 | 8.740 | -0.165 | -1.85% | 8.905 | 9.095 | 8.710 |
Jul 22, 2024 | 8.885 | 0.295 | 3.43% | 8.590 | 8.965 | 8.590 |
Jul 19, 2024 | 8.550 | -0.085 | -0.98% | 8.635 | 8.695 | 8.515 |
Jul 18, 2024 | 8.740 | 0.155 | 1.81% | 8.585 | 8.915 | 8.555 |
Jul 17, 2024 | 8.705 | 0.070 | 0.81% | 8.635 | 8.745 | 8.460 |
Jul 16, 2024 | 8.675 | -0.060 | -0.69% | 8.735 | 8.845 | 8.585 |
Jul 15, 2024 | 8.895 | 0.055 | 0.62% | 8.840 | 9.015 | 8.710 |
Jul 12, 2024 | 8.970 | -0.225 | -2.45% | 9.195 | 9.300 | 8.870 |
Jul 11, 2024 | 9.215 | -0.025 | -0.27% | 9.240 | 9.320 | 8.800 |
Jul 10, 2024 | 9.555 | 0.070 | 0.74% | 9.485 | 9.840 | 9.485 |
Jul 9, 2024 | 9.360 | -0.415 | -4.25% | 9.775 | 10.025 | 9.290 |
Jul 8, 2024 | 9.780 | 0.100 | 1.03% | 9.680 | 10.025 | 9.660 |
Jul 5, 2024 | 9.725 | 0.035 | 0.36% | 9.690 | 10.005 | 9.655 |
Jul 4, 2024 | 9.675 | 0.095 | 0.99% | 9.580 | 9.755 | 9.395 |
Jul 3, 2024 | 9.390 | 0.210 | 2.29% | 9.180 | 9.445 | 9.180 |
Jul 2, 2024 | 9.110 | 0.130 | 1.45% | 8.980 | 9.170 | 8.925 |
Jul 1, 2024 | 8.985 | 0.000 | 0.00% | 8.985 | 9.195 | 8.925 |
Jun 28, 2024 | 8.865 | 0.465 | 5.54% | 8.400 | 8.960 | 8.400 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
About Evotec SE
Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.
Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com